carboxyamido-triazole has been researched along with Glioblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alavi, JB; Carson, KA; Fisher, JD; Grossman, SA; Lush, R; Mikkelsen, T; Rosenfeld, S | 1 |
| Jacobs, W; Kohn, EC; Mikkelsen, T; Nelson, K; Rosenblum, ML; Smith, R | 1 |
1 trial(s) available for carboxyamido-triazole and Glioblastoma
| Article | Year |
|---|---|
Phase II clinical and pharmacologic study of radiation therapy and carboxyamido-triazole (CAI) in adults with newly diagnosed glioblastoma multiforme.
Topics: Administration, Oral; Adult; Aged; Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Calcium Channel Blockers; Case-Control Studies; Chemotherapy, Adjuvant; Drug Interactions; Glioblastoma; Humans; Kaplan-Meier Estimate; Middle Aged; Radiotherapy, Adjuvant; Treatment Outcome; Triazoles; United States | 2007 |
1 other study(ies) available for carboxyamido-triazole and Glioblastoma
| Article | Year |
|---|---|
Inhibitory effects of CAI in glioblastoma growth and invasion.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Adhesion; Cell Division; Gelatinases; Glioblastoma; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Neoplasm Invasiveness; Triazoles; Tumor Cells, Cultured | 1997 |